Bilateral and Unilateral Horizontal Strabismus Surgery

Sponsor
Minia University (Other)
Overall Status
Completed
CT.gov ID
NCT04199286
Collaborator
(none)
40
2
2
17.8
20
1.1

Study Details

Study Description

Brief Summary

This study was done in alternating strabismus patients to compare symmetrical muscle surgery and asymmetrical one as regard efficacy and lateral incomitance after surgery

Condition or Disease Intervention/Treatment Phase
  • Procedure: symmetrical and asymmetrical horizontal strabismus surgery
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Assessment of Symmetrical and Asymmetrical Horizontal Strabismus Surgery: Efficacy and Lateral Incomitance
Actual Study Start Date :
Dec 21, 2019
Actual Primary Completion Date :
Mar 1, 2021
Actual Study Completion Date :
Jun 14, 2021

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Asymmetrical surgery

This asymmetrical horizontal muscle surgery done as recess-resect in one eye or 3 muscle surgery

Procedure: symmetrical and asymmetrical horizontal strabismus surgery
surgery was done on the medial rectus muscle on both eyes, lateral rectus muscle in both eyes or medial and lateral rectus muscle in one eye

Active Comparator: Symmetrical

This symmetrical horizontal muscle surgery includes bilateral medial rectus recession in esotropia cases or bilateral lateral rectus recession in exotropia

Procedure: symmetrical and asymmetrical horizontal strabismus surgery
surgery was done on the medial rectus muscle on both eyes, lateral rectus muscle in both eyes or medial and lateral rectus muscle in one eye

Outcome Measures

Primary Outcome Measures

  1. There was 95% success rate in asymmetrical group compared with 90% in symmetrical one [one and half year]

    This result was measured by simultaneous prism cover test and expressed in prism diopter

Eligibility Criteria

Criteria

Ages Eligible for Study:
4 Years to 28 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • more than 3 years old.

  • alternating esotropia or exotropia

Exclusion Criteria:
  • unilateral strabismus

  • paralytic or restrictive strabismus

Contacts and Locations

Locations

Site City State Country Postal Code
1 Faculty of Medicine Minya Minia Egypt 61111
2 Mohamed F K Ibrahiem Minya Egypt 61111

Sponsors and Collaborators

  • Minia University

Investigators

  • Principal Investigator: Sahar TA Abdelaziz, MD, Assistant professor

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Mohamed Farag Khalil Ibrahiem, Assistant Professor, Minia University
ClinicalTrials.gov Identifier:
NCT04199286
Other Study ID Numbers:
  • Minia University Hospital
First Posted:
Dec 13, 2019
Last Update Posted:
Jun 18, 2021
Last Verified:
Jun 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 18, 2021